World Bile Duct Cancer Day 2026
- February 13, 2026
- admin
- 0
World Bile Duct Cancer Day 2026
On February 13, 2026, the Cholangiocarcinoma Research Institute, Khon Kaen University, and the Cholangiocarcinoma Foundation, in collaboration with the Cholangiocarcinoma Center of Excellence, Srinakarin Hospital, Faculty of Medicine, Khon Kaen University, organized the "World CCA's Day 2026" screening event for liver fluke and cholangiocarcinoma. The event was held at the activity area on the 1st floor and the surgical examination room on the 1st floor of the Kalyaniwattana Building, Faculty of Medicine, Khon Kaen University.
This event was honored by the presence of Prof. Dr. Thidarat Boonmas, Vice President for Enterprise and Sustainable Society, Khon Kaen University, who presided over the opening ceremony. The report was given by Prof. Dr. Somsak Tiemkao, Director of Srinakarin Hospital, and the background of the event was presented by Dr. Ruangsap Thueannadee, President of the Cholangiocarcinoma Foundation.
This event included educational sessions on "Understanding Bile Duct Cancer, Screening, and Treatment" presented by Assoc. Prof. Dr. Atthaphol Titapan, Department of Surgery, Faculty of Medicine, Khon Kaen University; and "Bile Duct Cancer and Treatment with Chemotherapy and Radiation Therapy" presented by Dr. Thanachai Saenlang, Department of Internal Medicine, Faculty of Medicine, Khon Kaen University. There was also a sharing of experiences regarding treatment and self-care for bile duct cancer patients by Mr. Smith Suetrong, a former bile duct cancer patient.
In addition to educational lectures, screening for liver fluke infection was provided using the rapid urine liver fluke detection kit OVATK, and ultrasound screening for high-risk groups was also conducted. Over 325 members of the public and healthcare personnel received these services. Of the 325 urine samples tested, 12 were found to be infected with liver fluke (3.7%), and all received anthelmintic medication. Ultrasound screening for bile duct cancer was performed on 308 people, with 2 suspected cases (CCA) (0.65%), and 5 were referred for other reasons such as kidney stones or liver cysts.
